A Phase 2, Multiple-Dose Study of The Efficacy and Safety of Wafermine™ (Sublingual Ketamine) in Participants Experiencing Acute Post-Operative Bunionectomy or Abdominoplasty Pain
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2018
At a glance
- Drugs Ketamine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors iX Biopharma
- 16 Mar 2018 Planned number of patients changed from 135 to 125.
- 16 Mar 2018 Planned End Date changed from 28 Mar 2018 to 12 Jun 2018.
- 16 Mar 2018 Planned primary completion date changed from 28 Mar 2018 to 12 Jun 2018.